Senior Oncology Safety Director - Pharmacovigilance Leader

GSK; Irvine; On-site; GBP 120,000 - 180,000; Full time

Job summary

GSK is seeking a Scientific Director to lead pharmacovigilance activities and risk mitigation for oncology assets in clinical development. This role shapes safety strategy, partners with cross-functional teams, and ensures robust benefit-risk profiles for patients globally.

The successful candidate will drive safety data interpretation, contribute to regulatory submissions, and mentor junior staff, while collaborating with Safety Physicians and governance bodies to address complex safety issues.

Qualifications

• Degree in a health or life sciences discipline.
• Extensive experience in pharmacovigilance or drug safety.
• Experience with signal detection and risk management in clinical development.
• Knowledge of global pharmacovigilance requirements.

Responsibilities

• Lead pharmacovigilance activities and risk mitigation strategies for oncology assets.
• Drive evaluation and interpretation of safety data, including signal detection.
• Develop strategic approaches for safety evaluation within clinical development programs.
• Contribute to safety components of global regulatory submissions (INDs, DSURs, IBs).
• Mentor and coach junior team members; lead cross-functional safety activities.

Skills

Pharmacovigilance

Safety evaluation

Risk management

Regulatory submissions

Cross-functional leadership

Education

Bachelor's degree in health or life sciences

PharmD/MD/PhD preferred

Job description

GSK is seeking a Scientific Director to lead pharmacovigilance activities and risk mitigation for oncology assets in clinical development. This role shapes safety strategy, partners with cross-functional teams, and ensures robust benefit-risk profiles for patients globally.

The successful candidate will drive safety data interpretation, contribute to regulatory submissions, and mentor junior staff, while collaborating with Safety Physicians and governance bodies to address complex safety issues.